Mycotic osteomyelitis in a dog following nasal aspergillosis.
Moore
A H
AH
Department of Clinical Veterinary Science, University of Bristol.
Hanna
F Y
FY
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000662:veterinary*; D001230:Aspergillus / Q000302:isolation & purification; D004283:Dog Diseases / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D004285:Dogs; D005534:Foot Diseases / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary; D007794:Lameness, Animal / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D008297:Male; D009297:Nasal Mucosa / Q000382:microbiology; D010019:Osteomyelitis / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D010254:Paranasal Sinus Diseases / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology / Q000662:veterinary*; D011859:Radiography; D012912:Sneezing; D013264:Stifle / Q000000981:diagnostic imaging / Q000473:pathology; D013977:Tibia / Q000000981:diagnostic imaging / Q000473:pathology
D000900:Anti-Bacterial Agents